Applied DNA to Host Conference Call and Webcast Discussing Fiscal 2022 Third Quarter Results and Corporate Updates

Rhea-AI Summary

Applied DNA Sciences (NASDAQ: APDN) announced a conference call to discuss third-quarter fiscal results on August 11, 2022, at 4:30 p.m. ET. The call will be hosted by CEO Dr. James A. Hayward and CFO Beth Jantzen. Interested participants can access the call by dialing the provided numbers and are encouraged to connect through the company’s website for the webcast and presentation slides. Applied DNA is focused on developing PCR-based technologies for DNA production and detection across various markets.

Positive

• Plans to disclose financial results and corporate updates indicate transparency and engagement with investors.

Negative

• None.

STONY BROOK, N.Y.--(BUSINESS WIRE)-- Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in polymerase chain reaction ("PCR")-based technologies, today announced that Dr. James A. Hayward, president and CEO, and Beth Jantzen, chief financial officer, will host a conference call and webcast on Thursday, August 11, 2022, at 4:30 p.m. ET to provide financial results and corporate updates for the fiscal third quarter of 2022.

To access the conference call:

• U.S. callers should dial 1-844-887-9402, and international callers should dial +1-412-317-6798 approximately five minutes before the call begins.
• Participants should ask to be connected to the Applied DNA Earnings Conference Call.

The conference call and accompanying presentation slides will also be webcast and can be accessed from the “News & Events” section of the Applied DNA website at https://investors.adnas.com/. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

About Applied DNA Sciences

Applied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid ("DNA"). Using the polymerase chain reaction ("PCR") to enable both the production and detection of DNA, we operate in three primary business markets: (i) the manufacture of DNA for use in nucleic acid-based therapeutics; (ii) the detection of DNA in molecular diagnostics testing services; and (iii) the manufacture and detection of DNA for industrial supply chain security services.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

The Company's common stock is listed on NASDAQ under the ticker symbol 'APDN,' and its publicly traded warrants are listed on OTC under the ticker symbol 'APPDW.'

View source version on businesswire.com: https://www.businesswire.com/news/home/20220808005722/en/

Investor Relations: Sanjay M. Hurry, 917-733-5573, sanjay.hurry@adnas.com

Web: www.adnas.com

Twitter: @APDN

Source: Applied DNA Sciences, Inc.

FAQ

What is the date of Applied DNA Sciences' upcoming earnings call?

The earnings call is scheduled for August 11, 2022, at 4:30 p.m. ET.

Who will host the earnings call for Applied DNA Sciences?

The earnings call will be hosted by CEO Dr. James A. Hayward and CFO Beth Jantzen.

How can I access the Applied DNA Sciences earnings conference call?

You can access the call by dialing 1-844-887-9402 (U.S.) or +1-412-317-6798 (international) five minutes before the call starts.

Where can I find the presentation slides for the earnings call?

The presentation slides will be available on the Applied DNA website in the 'News & Events' section.

What is the focus area of Applied DNA Sciences?

Applied DNA Sciences develops PCR-based technologies for DNA production and detection in therapeutics, diagnostics, and supply chain security.